Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02591654
Title MRI/PET Imaging to Assess Response to Pembrolizumab in Metastatic Melanoma
Acronym MPAK
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Columbia University
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Columbia University Irving Medical Center / NewYork-Presbyterian Hospital New York New York 10032 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field